136 related articles for article (PubMed ID: 30221696)
1. LIMD2 targeted by miR‑34a promotes the proliferation and invasion of non‑small cell lung cancer cells.
Wang F; Li Z; Xu L; Li Y; Li Y; Zhang X; Wang Y; Liu D
Mol Med Rep; 2018 Nov; 18(5):4760-4766. PubMed ID: 30221696
[TBL] [Abstract][Full Text] [Related]
2. miR‑671‑3p is downregulated in non‑small cell lung cancer and inhibits cancer progression by directly targeting CCND2.
Yao Y; Zhou Y; Fu X
Mol Med Rep; 2019 Mar; 19(3):2407-2412. PubMed ID: 30664171
[TBL] [Abstract][Full Text] [Related]
3. miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cells.
Tang Q; Li M; Chen L; Bi F; Xia H
Int J Oncol; 2018 Oct; 53(4):1732-1742. PubMed ID: 30066855
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of LIMD2 promotes the progression of non-small cell lung cancer.
Zhang F; Qin S; Xiao X; Tan Y; Hao P; Xu Y
Oncol Lett; 2019 Aug; 18(2):2073-2081. PubMed ID: 31423280
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.
Tan Y; Hu H; Tan W; Jin L; Liu J; Zhou H
Mol Med Rep; 2016 Nov; 14(5):4422-4428. PubMed ID: 27665963
[TBL] [Abstract][Full Text] [Related]
6. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
7. microRNA‑577 inhibits cell proliferation and invasion in non‑small cell lung cancer by directly targeting homeobox A1.
Men L; Nie D; Nie H
Mol Med Rep; 2019 Mar; 19(3):1875-1882. PubMed ID: 30628697
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA LINC00978 promotes cell proliferation and invasion in non‑small cell lung cancer by inhibiting miR‑6754‑5p.
Li X; Ren Y; Zuo T
Mol Med Rep; 2018 Nov; 18(5):4725-4732. PubMed ID: 30221669
[TBL] [Abstract][Full Text] [Related]
9. miR‑497 suppresses malignant phenotype in non‑small cell lung cancer via targeting KDR.
Xia Y; Hu C; Lian L; Hui K; Wang L; Qiao Y; Liu L; Liang L; Jiang X
Oncol Rep; 2019 Jul; 42(1):443-452. PubMed ID: 31115562
[TBL] [Abstract][Full Text] [Related]
10. miR-768-3p is involved in the proliferation, invasion and migration of non-small cell lung carcinomas.
Xie Z; Chen W; Chen Y; Wang X; Gao W; Liu Y
Int J Oncol; 2017 Nov; 51(5):1574-1582. PubMed ID: 29048613
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR-4286 is an unfavorable prognostic marker in individuals with non-small cell lung cancer.
An X; Ge J; Guo H; Mi H; Zhou J; Liu Y; Weiyue ; Wu Z
J Cell Biochem; 2019 Oct; 120(10):17573-17583. PubMed ID: 31111550
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
Guo D; Wang Y; Ren K; Han X
Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
[TBL] [Abstract][Full Text] [Related]
13. miR‑379‑5p inhibits cell proliferation and promotes cell apoptosis in non‑small cell lung cancer by targeting β‑arrestin‑1.
Jiang Y; Zhu P; Gao Y; Wang A
Mol Med Rep; 2020 Dec; 22(6):4499-4508. PubMed ID: 33173959
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA PSMA3‑AS1 functions as a microRNA‑409‑3p sponge to promote the progression of non‑small cell lung carcinoma by targeting spindlin 1.
Wang L; Wu L; Pang J
Oncol Rep; 2020 Oct; 44(4):1550-1560. PubMed ID: 32945481
[TBL] [Abstract][Full Text] [Related]
15. Propofol suppresses the progression of non‑small cell lung cancer via downregulation of the miR‑21‑5p/MAPK10 axis.
Wu X; Li X; Xu G
Oncol Rep; 2020 Aug; 44(2):487-498. PubMed ID: 32468043
[TBL] [Abstract][Full Text] [Related]
16. Upregulated microRNA‑671‑3p promotes tumor progression by suppressing forkhead box P2 expression in non‑small‑cell lung cancer.
Li ZY; Zhang ZZ; Bi H; Zhang QD; Zhang SJ; Zhou L; Zhu XQ; Zhou J
Mol Med Rep; 2019 Oct; 20(4):3149-3159. PubMed ID: 31432170
[TBL] [Abstract][Full Text] [Related]
17. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
[TBL] [Abstract][Full Text] [Related]
18. miR-204 suppresses non-small-cell lung carcinoma (NSCLC) invasion and migration by targeting JAK2.
Wang P; Lv HY; Zhou DM; Zhang EN
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323056
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET.
Wei B; Huang QY; Huang SR; Mai W; Zhong XG
Mol Med Rep; 2015 Oct; 12(4):5255-61. PubMed ID: 26238271
[TBL] [Abstract][Full Text] [Related]
20. LASP-1, regulated by miR-203, promotes tumor proliferation and aggressiveness in human non-small cell lung cancer.
Zheng J; Wang F; Lu S; Wang X
Exp Mol Pathol; 2016 Feb; 100(1):116-24. PubMed ID: 26683818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
